The Role of Stromal Myofibroblast and Extracellular Matrix in Tumor Angiogenesis

Genes and Cancer

Volumn 2, Issue 12, 2011, Pages 1139-1145

  Vong, Sylvia ^a   Kalluri, Raghu ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

angiogenesis; extracellular matrix; myofibroblasts; stroma

Indexed keywords

ADAM PROTEIN; MATRIX METALLOPROTEINASE; SCLEROPROTEIN;

CELL FUNCTION; CELL INTERACTION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STROMA CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84858592019     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911423940     Document Type: Review

References (102)

1. Folkman J.Tumor angiogenesis: therapeutic implications.N Engl J Med. 1971;285:1182-6.
2. Gimbrone MAJ,Leapman SB,Cotran RS,Folkman J.Tumor dormancy in vivo by prevention of neovascularization.J Exp Med. 1972;136:261-76.
3. Folkman J,Kalluri R.Cancer without disease.Nature. 2004;427:787.
4. Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation.Cell. 2011;144:646-74.
5. Kalluri R,Zeisberg M.Fibroblasts in cancer.Nat Rev Cancer. 2006;6:392-401.
6. Coussens LM,Werb Z.Inflammation and cancer.Nature. 2002;420:860-7.
7. van der Rest M,Garrone R.Collagen family of proteins.FASEB J. 1991;5:2814-23.
8. Giancotti FG,Ruoslahti E.Integrin signaling.Science. 1999;285:1028-32.
9. Xu J,Rodriguez D,Petitclerc E, et al.Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.J Cell Biol. 2001;154:1069-79.
10. Hodivala-Dilke KM,McHugh KP,Tsakiris DA, et al.β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.J Clin Invest. 1999;103:229-38.
11. Bader BL,Rayburn H,Crowley D,Hynes RO.Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αv integrins.Cell. 1998;95:507-19.
12. Huang XZ,Wu JF,Ferrando R, et al.Fatal bilateral chylothorax in mice lacking the integrin α9β1.Mol Cell Biol. 2000;20:5208-15.
13. Reynolds LE,Wyder L,Lively JC, et al.Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins.Nat Med. 2002;8:27-34.
14. Zhu J,Motejlek K,Wang D, et al.β8 integrins are required for vascular morphogenesis in mouse embryos.Development. 2002;129:2891-903.
15. Stupack DG,Cheresh DA.Integrins and angiogenesis.Curr Top Dev Biol. 2004;64:207-38.
16. Abraham S,Kogata N,Fassler R, et al.Integrin β1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability.Circ Res. 2008;102:562-70.
17. Lee S,Jilani SM,Nikolova GV, et al.Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.J Cell Biol. 2005;169:681-91.
18. Clark CJ,Sage EH.A prototypic matricellular protein in the tumor microenvironment -where there's SPARC, there's fire.J Cell Biochem. 2008;104:721-32.
19. Bornstein P.Thrombospondins function as regulators of angiogenesis.J Cell Commun Sig. 2009;3:189-200.
20. Tanaka K,Hiraiwa N,Hashimoto H, et al.Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.Int J Cancer. 2004;108:31-40.
21. Zagzag D,Friedlander DR,Miller DC, et al.Tenascin expression in astrocytomas correlates with angiogenesis.Cancer Res. 1995;55:907-14.
22. Dai J,Peng L,Fan K, et al.Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.Oncogene. 2009;28:3412-22.
23. Chakraborty G,Jain S,Kundu GC.Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.Cancer Res. 2008;68:152-61.
24. O'Reilly MS,Boehm T,Shing Y, et al.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell. 1997;88:277-85.
25. Kim YM,Jang JW,Lee OH, et al.Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2.Cancer Res. 2000;60:5410-3.
26. Cooke VG,Kalluri R.Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.Methods Enzymol. 2008;444:1-19.
27. Magnon C,Galaup A,Mullan B, et al.Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with αvβ3 and αvβ5 integrins.Cancer Res. 2005;65:4353-61.
28. Nyberg P,Xie L,Kalluri R.Endogenous inhibitors of angiogenesis.Cancer Res. 2005;65:3967-79.
29. Itoh T,Tanioka M,Yoshida H, et al.Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.Cancer Res. 1998;58:1048-51.
30. Lederle W,Hartenstein B,Meides A, et al.MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.Carcinogenesis. 2010;31:1175-84.
31. Huang S,Van Arsdall M,Tedjarati S, et al.Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice.J Natl Cancer Inst. 2002;94:1134-42.
32. Fang J,Shing Y,Wiederschain D, et al.Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.Proc Nat Acad Sci U S A. 2000;97:3884-9.
33. Jodele S,Blavier L,Yoon JM,DeClerck YA.Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.Cancer Metastasis Rev. 2006;25:35-43.
34. Hawinkels LJ,Zuidwijk K,Verspaget HW, et al.VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.Eur J Cancer. 2008;44:1904-13.
35. Ito TK,Ishii G,Chiba H, et al.The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells.Oncogene. 2007;26:7194-203.
36. Kessenbrock K,Plaks V,Werb Z.Matrix metalloproteinases: regulators of the tumor microenvironment.Cell. 2010;141:52-67.
37. Murphy AN,Unsworth EJ,Stetler-Stevenson WG.Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993;157:351-8.
38. Seo DW,Li H,Guedez L, et al.TIMP-2 Mediated Inhibition of Angiogenesis: An MMP-Independent Mechanism.Cell. 2003;114:171-80.
39. Qi JH,Ebrahem Q,Moore N, et al.A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.Nat Med. 2003;9:407-15.
40. Rocks N,Paulissen G,El Hour M, et al.Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.Biochimie. 2008;90:369-79.
41. Trochon V,Li H,Vasse M, et al.Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro.Angiogenesis. 1998;2:277-85.
42. Mazzocca A,Coppari R,De Franco R, et al.A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.Cancer Res. 2005;65:4728-38.
43. Göoz P,Göoz M,Baldys A,Hoffman S.ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis.Biochem Biophys Res Commun. 2009;380:33-8.
44. Black RA,White JM.ADAMs: focus on the protease domain.Curr Op Cell Biol. 1998;10:654-9.
45. Qi H,D Rand M,Wu X, et al.Processing of the notch ligand delta by the metalloprotease Kuzbanian.Science. 1999;283:91-4.
46. Vazquez F,Hastings G,Ortega MA, et al.METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity.J Biol Chem. 1999;274:23349-57.
47. Dubail J,Kesteloot F,Deroanne C, et al.ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity.Cell Mol Life Sci. 2010;67:4213-32.
48. Lo PH,Lung HL,Cheung AK, et al.Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis.Cancer Res. 2010;70:5567-76.
49. El Hour M,Moncada-Pazos A,Blacher S, et al.Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis.Oncogene. 2010;29:3025-32.
50. Korff T,Augustin HG.Tensional forces in fibrillar extracellular matrices control directional capillary sprouting.J Cell Sci. 1999;112:3249-58.
51. Krishnan L,Underwood CJ,Maas S, et al.Effect of mechanical boundary conditions on orientation of angiogenic microvessels.Cardiovasc Res. 2008;78:324-32.
52. Bauer AL,Jackson TL,Jiang Y.Topography of extracellular matrix mediates vascular morphogenesis and migration speeds in angiogenesis.PLoS Comput Biol. 2009;5:e1000445.
53. Myers KA,Applegate KT,Danuser G, et al.Distinct ECM mechanosensing pathways regulate microtubule dynamics to control endothelial cell branching morphogenesis.J Cell Biol. 2011;192:321-34.
54. Maeda T,Desouky J,Friedl A.Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.Oncogene. 2006;25:1408-12.
55. Yang N,Mosher R,Seo S,Beebe D,Friedl A.Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility.Am J Pathol. 2011;178:325-35.
56. Kirkpatrick ND,Andreou S,Hoying JB, et al.Live imaging of collagen remodeling during angiogenesis.Am J Physiol Heart Circ Physiol. 2007;292:H3198-206.
57. Granot D,Addadi Y,Kalchenko V, et al.In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors.Cancer Res. 2007;67:9180-9.
58. Orimo A,Gupta PB,Sgroi DC, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.Cell. 2005;121:335-48.
59. Tuxhom JA,McAlhany SJ,Dang TD, et al.Stromal Cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.Cancer Res. 2002;62:3298-307.
60. Dong J,Grunstein J,Tejada M, et al.VEGF-null cells require PDGFRα signaling-mediated stromal fibroblast recruitment for tumorigenesis.EMBO J. 2004;23:2800-10.
61. Crawford Y,Kasman I,Yu L, et al.PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.Cancer Cell. 2009;15:21-34.
62. Hlatky L,Tsionou C,Hahnfeldt P, et al.Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression.Cancer Res. 1994;54:6083-6.
63. Fang J,Yan L,Shing Y,Moses MA.HIF-1α-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.Cancer Res. 2001;61:5731-5.
64. Bisson C,Blacher S,Polette M, et al.Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells.Int J Cancer. 2003;105:7-13.
65. Basset P,Bellocq JP,Wolf C, et al.A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.Nature. 1990;348:699-704.
66. Poulsom R,Pignatelli M,Stetler-Stevenson WG, et al.Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.Am J Pathol. 1992;141:389-96.
67. Poulsom R,Hanby AM,Pignatelli M, et al.Expression of gelatinase-A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.J Clin Pathol. 1993;46:429-36.
68. Tang Y,Nakada MT,Kesavan P, et al.Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases.Cancer Res. 2005;65:3193-9.
69. Sameshima T,Nabeshima K,Toole BP, et al.Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN)(CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.Cancer Lett. 2000;157:177-84.
70. Moncada-Pazos A,Obaya AJ,Fraga MF, et al.The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.J Cell Sci. 2009;122:2906-13.
71. Schwettmann L,Wehmeier M,Jokovic D, et al.Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.J Hepatol. 2008;49:243-50.
72. Orimo A,Gupta PB,Sgroi DC, et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.Cell. 2005;121:335-48.
73. Allinen M,Beroukhim R,Cai L, et al.Molecular characterization of the tumor microenvironment in breast cancer.Cancer Cell. 2004;6:17-32.
74. Orimo A,Tomioka Y,Shimizu Y, et al.Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression.Clin Cancer Res. 2001;7:3097.
75. Erez N,Truitt M,Olson P,Hanahan D.Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-[kappa] B-Dependent Manner.Cancer Cell. 2010;17:135-47.
76. Silzle T,Kreutz M,Dobler MA, et al.Tumor-associated fibroblasts recruit blood monocytes into tumor tissue.Eur J Immunol. 2003;33:1311-20.
77. Noonan DM,De Lerma Barbaro A,Vannini N, et al.Inflammation, inflammatory cells and angiogenesis: decisions and indecisions.Cancer Metastasis Rev. 2008;27:31-40.
78. Zumsteg A,Christofori G.Corrupt policemen: inflammatory cells promote tumor angiogenesis.Curr Op Oncol. 2009;21:60-70.
79. Bhowmick NA,Chytil A,Plieth D, et al.TGF-ß signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.Science. 2004;303:848-51.
80. Katajisto P,Vaahtomeri K,Ekman N, et al.LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis.Nat Genet. 2008;40:455-9.
81. Kurose K,Gilley K,Matsumoto S,Watson PH,Zhou XP,Eng C.Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.Nat Genet. 2002;32:355-7.
82. Wernert N,Locherbach C,Wellmann A, et al.Presence of genetic alterations in microdissected stroma of human colon and breast cancers.Anticancer Res. 2001;21:2259-64.
83. Hill R,Song Y,Cardiff RD, et al.Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.Cell. 2005;123:1001-11.
84. Dameron KM,Volpert OV,Tainsky MA, et al.Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.Science. 1994;265:1582-4.
85. Addadi Y,Moskovits N,Granot D, et al.p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.Cancer Res. 2010;70:9650-8.
86. Pal S,Datta K,Mukhopadhyay D.Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.Cancer Res. 2001;61:6952-7.
87. Ueba T,Nosaka T,Takahashi JA, et al.Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.Proc Nat Acad Sci U S A. 1994;91:9009-13.
88. Desmoulière A,Guyot C,Gabbiani G.The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.Int J Dev Biol. 2004;48:509-18.
89. Dvorak HF.Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Eng J Med. 1986;315:1650-9.
90. Schäfer M,Werner S.Cancer as an overhealing wound: an old hypothesis revisited.Nat Rev Mol Cell Biol. 2008;9:628-38.
91. Eck SM,Cote AL,Winkelman WD, et al.CXCR4 and MMP-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells.Mol Cancer Res. 2009;7:1033-44.
92. Sato N,Maehara N,Goggins M.Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts.Cancer Res. 2004;64:6950-9.
93. Cosgrove GP,Brown KK,Schiemann WP, et al.Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.Am J Respir Crit Care Med. 2004;170:242-51.
94. Corpechot C,Barbu V,Wendum D, et al.Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis.Hepatology. 2002;35:1010-21.
95. Barsky SH,Nelson LL,Levy VA.Tumour desmoplasia inhibits angiogenesis.Lancet. 1987;2:1336-7.
96. Yauch RL,Gould SE,Scales SJ, et al.A paracrine requirement for hedgehog signalling in cancer.Nature. 2008;455:406-10.
97. Tian H,Callahan CA,DuPree KJ, et al.Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis.Proc Nat Acad Sci U S A. 2009;106:4254-9.
98. Bailey JM,Swanson BJ,Hamada T, et al.Sonic hedgehog promotes desmoplasia in pancreatic cancer.Clin Cancer Res. 2008;14:5995-6004.
99. Olive KP,Jacobetz MA,Davidson CJ, et al.Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.Science. 2009;324:1457-61.
100. Santos AM,Jung J,Aziz N, et al.Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.J Clin Invest. 2009;119:3613-25.
101. Gilbertson RJ,Rich JN.Making the tumour's bed: glioblastoma stem cells and their vascular niche.Nat Rev Cancer. 2007;7:733-6.
102. Zeisberg EM,Potenta S,Xie L, et al.Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.Cancer Res. 2007;67:10123-8.